- Home
- PHAT vs RRBI Comparison
PHAT vs RRBI Comparison
Compare PHAT & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- RRBI
- Stock Information
- Founded
- PHAT 2018
- RRBI 1998
- Country
- PHAT United States
- RRBI United States
- Employees
- PHAT N/A
- RRBI N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- RRBI Hotels/Resorts
- Sector
- PHAT Health Care
- RRBI Consumer Discretionary
- Exchange
- PHAT Nasdaq
- RRBI Nasdaq
- Market Cap
- PHAT 339.8M
- RRBI 333.5M
- IPO Year
- PHAT 2019
- RRBI 2019
- Fundamental
- Price
- PHAT $3.96
- RRBI $51.48
- Analyst Decision
- PHAT Strong Buy
- RRBI
- Analyst Count
- PHAT 5
- RRBI 0
- Target Price
- PHAT $22.50
- RRBI N/A
- AVG Volume (30 Days)
- PHAT 1.2M
- RRBI 6.8K
- Earning Date
- PHAT 05-08-2025
- RRBI 04-28-2025
- Dividend Yield
- PHAT N/A
- RRBI 0.94%
- EPS Growth
- PHAT N/A
- RRBI 1.85
- EPS
- PHAT N/A
- RRBI 4.95
- Revenue
- PHAT $55,252,000.00
- RRBI $108,680,000.00
- Revenue This Year
- PHAT $202.23
- RRBI N/A
- Revenue Next Year
- PHAT $113.81
- RRBI $5.59
- P/E Ratio
- PHAT N/A
- RRBI $10.00
- Revenue Growth
- PHAT 8001.47
- RRBI 1.74
- 52 Week Low
- PHAT $3.81
- RRBI $42.78
- 52 Week High
- PHAT $19.71
- RRBI $62.13
- Technical
- Relative Strength Index (RSI)
- PHAT 37.83
- RRBI 52.35
- Support Level
- PHAT $3.87
- RRBI $49.04
- Resistance Level
- PHAT $5.09
- RRBI $50.96
- Average True Range (ATR)
- PHAT 0.59
- RRBI 1.66
- MACD
- PHAT -0.10
- RRBI 0.26
- Stochastic Oscillator
- PHAT 6.12
- RRBI 70.73
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.